Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
0.8749
-0.0478 (-5.18%)
At close: Jan 30, 2026, 4:00 PM EST
0.8799
+0.0050 (0.57%)
After-hours: Jan 30, 2026, 7:32 PM EST
Firefly Neuroscience Revenue
Firefly Neuroscience had revenue of $388.00K in the quarter ending September 30, 2025, with 1,075.76% growth. This brings the company's revenue in the last twelve months to $783.00K, up 958.11% year-over-year. In the year 2024, Firefly Neuroscience had annual revenue of $108.00K, down -78.31%.
Revenue (ttm)
$783.00K
Revenue Growth
+958.11%
P/S Ratio
12.53
Revenue / Employee
$60,231
Employees
13
Market Cap
11.80M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 108.00K | -390.00K | -78.31% |
| Dec 31, 2023 | 498.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 6.86M | 148.57K | 2.21% |
| Dec 31, 2009 | 6.71M | 17.92K | 0.27% |
| Dec 31, 2008 | 6.69M | -3.26M | -32.75% |
| Dec 31, 2007 | 9.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nvni Group | 36.58M |
| Smith Micro Software | 18.36M |
| Intelligent Protection Management | 17.76M |
| NetClass Technology | 9.99M |
| CXApp | 5.22M |
| Webus International | 4.97M |
| Perpetuals.com | 3.08M |
| Future FinTech Group | 2.67M |
AIFF News
- 2 months ago - Firefly Neuroscience Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America - GlobeNewsWire
- 5 months ago - Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR' Platform - GlobeNewsWire
- 7 months ago - Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research - GlobeNewsWire
- 7 months ago - Firefly Neuroscience to be Added to the Russell Microcap® Index - GlobeNewsWire
- 8 months ago - Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients - GlobeNewsWire
- 9 months ago - Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. - GlobeNewsWire
- 9 months ago - Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. - GlobeNewsWire